Recent BioUtah News & Events

Sumitomo Pharma Oncology to Present Preliminary Clinical Data Evaluating Investigational Agent TP-3654

On November 17, Sen. Mike Lee (R-UT) introduced the “Biosimilar Red Tape Elimination Act” to increase patient access to biosimilars and reduce costs by easing switching studies required to allow a biosimilar to be substituted for a biologic. View a one-page summary HERE. Currently, pharmacists can substitute generics in lieu of their branded counterparts without […]

The University of Utah Health has launched NEW DIGITAL HEALTH INITIATIVE

Kåre Schultz to Retire After a Transformative Five-Year Tenure Setting the Stage for an Exciting Future

SALT LAKE CITY, Nov. 10, 2022 (GLOBE NEWSWIRE) — Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced the launch of UroSuite, a comprehensive suite of genetic risk assessment tests that cover every stage of prostate cancer care. UroSuite includes Myriad’s Prolaris® Prostate Cancer Test, MyRisk™ Hereditary Cancer Test, […]

CenExel announces a new Clinical Sciencesbusiness unit and more.

On Thursday, November 10, 2022, the BioHIve gathered at the Salt Palace for the annual BioHive Summit presented by Mayer Brown. It was the first time in three years the industry had gathered in person. The pent up demand for in-person networking combined with quality programming resulted in record registration of over 700 participants. Governor […]

Betty Iverson Retirement Announced

PolarityTE provided a business update and reported financial results for the quarterly period ended September 30, 2022.

PolarityTE confirmed that on November 1, 2022, it received an unsolicited, non-binding offer (followed by an amended offer on November 8, 2022) from Michael Brauser to acquire all of the outstanding common stock of the Company not owned by him for $1.25 per share in cash.

Clene announced that it has entered into a securities purchase agreement with certain existing stockholders.

The primary endpoint of adjusted ALSFRS-R and secondary endpoints of CAFS and SVC were not met at 24 weeks Prespecified exploratory analyses of the secondary survival endpoint for the 30 mg dose demonstrated a >90% reduction in risk of death or risk of death/permanently assisted ventilation at 24 weeks Survival signal consistent with prior results […]

$67.5 million tuck-in acquisition strengthens Myriad’s Women’s Health portfolio of prenatal products.

Myriad Genetics announced financial results for its third quarter ended September 30, 2022 and provided an update on business performance.

Renalytix announced its full year results for the twelve months ended 30 June 2022.

Merit Medical Systems announced revenue of $287.2 million for the quarter ended September 30, 2022.

UTMD Reports Financial Performance for Third Calendar Quarter and Nine Months 2022

Renalytix announced that the Federal Medicare Administrative Contractor (MAC) National Government Services (NGS) has initiated payment of claims for KidneyIntelX testing for patients with Medicare coverage.

The Women’s Tech Council announced eight award recipients from its twenty one finalists.

Geneial announces a multimillion dollar, non-dilutive award from the National Human Genome Research Institute to fund the development of their secure, decentralized platform.

SINTX announces the receipt of a Phase II award of $1.1M, issued by the U.S. Department of Energy (DOE) to develop, design and characterize 3D-printed alumina ceramic heat exchangers for heating, ventilation, and air conditioning systems (HVAC).

SINTX announced a Phase I grant of $275k awarded by the National Institutes of Health (NIH) to develop and test an antimicrobial trauma device.

CNS Clinical Research Veteran Brings Extensive Expertise in Global Project Management & Operations

Foldax announced that medtech veteran Gregory D. Casciaro has been named Chief Executive Officer of the company, effective yesterday.